Gajera, Gemini
Godse, Chhaya
DeSouza, Anselm
Mehta, Dilip
Kothari, Vijay
Article History
Received: 22 September 2022
Accepted: 16 June 2023
First Online: 3 July 2023
Declarations
:
: Three of the authors DM, AD, and CG are from Viridis Biopharma Pvt. Ltd., who manufacture and market Silversol®. However this has not affected anyway the design of the study or interpretation of data. Rest of the authors have no competing interests to declare.
: Though <i>C. elegans</i> is a valid platform for preliminary investigation on anthelmintic activity of any test formulation, it is not a parasite. The parasitic helminths may or may not exert a susceptibility profile similar to that of <i>C. elegans</i>. This study did not test Silversol<sup>®</sup> against any such parasitic helminth.
: Not Applicable.
: Not Applicable.